U
Unchained Labs
Helping biologics researchers break free from tools that just don’t cut it
About Unchained Labs
Unchained Labs is a life sciences company that specializes in providing innovative tools and technologies designed to address complex research and development challenges. The company serves scientists and researchers in the life sciences sector, offering solutions that enhance the efficiency and accuracy of their work. Operating in the global life sciences market, Unchained Labs focuses on developing automated instrumentation and consumables that streamline workflows and improve the precision of protein quantification and other critical research tasks. The business model revolves around the sale of high-tech instruments and consumables, as well as providing ongoing support and services to ensure optimal performance and customer satisfaction. Revenue is generated through direct sales, service contracts, and consumable sales, catering primarily to pharmaceutical companies, biotech firms, and academic research institutions.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Pleasanton, United States
- Employees
- 216
- Open positions
- 7
- Dealroom signal
- 66.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Accounting, Biotechnology, Oncology, Camping, DNA, Surgery, Neurology, Genetics and genomics, Non-Invasive medical devices and treatments, Product Research, Genome Engineering
- Client focus
- b2b
- Investment activity
- 4 companies, latest Jul 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Aug 2021 | $155M | — | Midcap Financial · Golub Capital | ↗ |
| ACQUISITIONOther financing | Apr 2021 | $435M | $435M | The Carlyle Group | — |
Growth signals
Latest recorded traffic for Unchained Labs is 27K monthly website visits, up 12.5% over the last three months. Unchained Labs's team declined 0.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
BlacktraceRoyston, United KingdomDesign, develop and manufacture the coolest cutting-edge scientific products and technologies, and sell these via market leading brands
→
Nanoview BiosciencesBoston, United StatesDeveloping proprietary products that support research, translation and delivery of precision medicine
$40Mvaluation
Rap.IDBerlin, GermanyA leading provider of systems used for particle identification in biopharmaceutical development and quality control
→
TrineanGhent, BelgiumBelgium based technology provider, bringing micro-volume molecular spectroscopy to the next level
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Standard Treasury
Midcap Financial
Golub Capital
Other known investors1 additional known investor
The Carlyle Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Unchained Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Unchained Labs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.